Head-To-Head Review: InfuSystem (NYSE:INFU) vs. Sigyn Therapeutics (NASDAQ:SIGY)

Sigyn Therapeutics (NASDAQ:SIGYGet Rating) and InfuSystem (NYSE:INFUGet Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Volatility & Risk

Sigyn Therapeutics has a beta of -0.92, indicating that its stock price is 192% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500.

Insider & Institutional Ownership

61.4% of InfuSystem shares are held by institutional investors. 78.5% of Sigyn Therapeutics shares are held by company insiders. Comparatively, 19.7% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Sigyn Therapeutics and InfuSystem’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sigyn Therapeutics N/A -1,214.45% -252.89%
InfuSystem 1.39% 3.11% 1.50%

Analyst Recommendations

This is a summary of current recommendations and price targets for Sigyn Therapeutics and InfuSystem, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sigyn Therapeutics 0 0 1 0 3.00
InfuSystem 0 0 0 0 N/A

Sigyn Therapeutics currently has a consensus price target of $0.93, indicating a potential upside of 295.74%. Given Sigyn Therapeutics’ higher possible upside, research analysts plainly believe Sigyn Therapeutics is more favorable than InfuSystem.

Valuation & Earnings

This table compares Sigyn Therapeutics and InfuSystem’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sigyn Therapeutics N/A N/A -$3.01 million N/A N/A
InfuSystem $102.38 million 1.86 $1.42 million $0.07 132.57

InfuSystem has higher revenue and earnings than Sigyn Therapeutics.


InfuSystem beats Sigyn Therapeutics on 7 of the 10 factors compared between the two stocks.

Sigyn Therapeutics Company Profile (Get Rating)

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company that treats inflammatory conditions by cytokine storm syndrome. It offers Sigyn Therapy, a blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. The company also engages in evaluating the Sigyn Therapy to address CytoVesicles that transport inflammatory cytokine cargos throughout the bloodstream. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.

InfuSystem Company Profile (Get Rating)

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.